Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pituitary gland

Medical therapy for acromegaly: can we predict response?

Nature Reviews Endocrinology volume 5, pages 425–427 (2009)Cite this article

Response to medical therapy for acromegaly is highly variable, with few predictive factors available to help clinicians make informed treatment choices. Researchers in the UK now suggest that prior radiotherapy might influence an individual's response to secondary therapy with dopamine agonists or somatostatin analogs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sherlock, M. et al. Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues. J. Clin. Endocrinol. Metab. 94, 1255–1263 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Melmed, S. et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Melmed, S. et al. Consensus statement: medical management of acromegaly. Eur. J. Endocrinol. 153, 737–740 (2005).

    Article  CAS  PubMed  Google Scholar 

  4. Freda, P. U. et al. Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 90, 4465–4473 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. Gola, M., Bonadonna, S., Mazziotti, G., Amato, G. & Giustina, A. Resistance to somatostatin analogs in acromegaly: an evolving concept? J. Endocrinol. Invest. 29, 86–93 (2006).

    Article  CAS  PubMed  Google Scholar 

  6. Jaffe, C. A. & Barkan, A. L. Treatment of acromegaly with dopamine agonists. Endocrinol. Metab. Clin. North Am. 21, 713–735 (1992).

    Article  CAS  PubMed  Google Scholar 

  7. Giustina, A. et al. Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000).

    CAS  PubMed  Google Scholar 

  8. Colao, A. et al. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 91, 85–92 (2006).

    Article  CAS  PubMed  Google Scholar 

  9. Bianchi, A. et al. Influence of growth hormone receptor D3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J. Clin. Endocrinol. Metab. 94, 2015–2022 (2009).

    Article  CAS  PubMed  Google Scholar 

  10. Fusco, A. et al. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 93, 2746–2750 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Brescia, Italy

    Andrea Giustina & Teresa Porcelli

Authors
  1. Andrea Giustina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa Porcelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Giustina.

Ethics declarations

Competing interests

Andrea Giustina declares the following associations: Ipsen (consultant and speakers bureau), Italfarmaco (consultant and speakers bureau), Novartis (consultant) and Pfizer (consultant and speakers bureau).

Teresa Porcelli declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giustina, A., Porcelli, T. Medical therapy for acromegaly: can we predict response?. Nat Rev Endocrinol 5, 425–427 (2009). https://doi.org/10.1038/nrendo.2009.146

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.146

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing